1. Home
  2. Browse
  3. HRA006122
HRA006122
   HRA006122.xlsx
Title:
Molecular mutation spectrums and subtyping in Primary Central Nervous System Lymphoma
Release date:
2023-11-30
Description:
The WES data of the 140 patients of PCNSL. The investigation of molecular mutation spectrums and subtyping in Primary Central Nervous System Lymphoma (PCNSL) within the Chinese population encounters numerous challenges. Firstly, due to PCNSL's low incidence rate and the inherent difficulty in obtaining samples, most current studies are limited by small sample sizes and are predominantly single-centered. This significantly restricts our ability to comprehensively understand the genetic mutation characteristics of PCNSL in the Chinese demographic. Additionally, molecular subtyping models proposed by international teams may not fully apply to Chinese PCNSL patients, given the variations in ethnicity, geographical factors, and other biological aspects. Addressing these key issues, this project aims to undertake the following research initiatives: Execute a multicenter, large-scale exome sequencing study tailored to the Chinese PCNSL population.
Data Accessibility:   
Controlled access Request Data
BioProject:
PRJCA021482
Study type:
Disease Study
Disease name:
diffuse large B-cell lymphoma
Data Access Committee

For each controlled access study, there is a corresponding Data Access Committee(DAC) to determine the access permissions. Access to actual data files is not managed by NGDC.


DAC NO.:
HDAC003376
DAC name:
PCNSL data of Prof. Wei Hua
Contact person:
Li Shengjie
Email:
lishengjie6363020@163.com
Description:
The DAC controls the data sharing of project and GSA-Human data titled Molecular mutation spectrums and subtyping in Primary Central Nervous System Lymphoma
Individuals & samples
Files
Request Data
Submitter:   Hua Wei / hs_huawei@126.com
Organization:   Huashan Hospital Fudan University
Submission date:   2023-11-22
Requests:   4